BRCA1 and ovarian adenocarcinoma: Among the CPGs, BRCA1 was significantly enriched in ovarian adenocarcinoma (Ovary-AdenoCA; Log2OR = 6.91, FDR = 9.63 × 10−6) and breast adenocarcinoma (Breast-AdenoCA; Log2OR = 4.81, FDR = 4.76 × 10−3) and BRCA2 was enriched in Breast-AdenoCA (Log2OR = 4.70, FDR = 6.93 × 10−5), pancreatic adenocarcinoma (Panc-AdenoCA; Log2OR = 4.12, FDR = 6.45 × 10−4) and Ovary-AdenoCA (Log2OR = 3.76, FDR = 9.03 × 10−3).